PaxMedica, Common Total Debt vs. Debt To Equity

PXMDDelisted Stock  USD 0.86  0.18  17.31%   
Considering PaxMedica, Common's profitability and operating efficiency indicators, PaxMedica, Common Stock may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in January. Profitability indicators assess PaxMedica, Common's ability to earn profits and add value for shareholders.
For PaxMedica, Common profitability analysis, we use financial ratios and fundamental drivers that measure the ability of PaxMedica, Common to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well PaxMedica, Common Stock utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between PaxMedica, Common's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of PaxMedica, Common Stock over time as well as its relative position and ranking within its peers.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Please note, there is a significant difference between PaxMedica, Common's value and its price as these two are different measures arrived at by different means. Investors typically determine if PaxMedica, Common is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PaxMedica, Common's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

PaxMedica, Common Stock Debt To Equity vs. Total Debt Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining PaxMedica, Common's current stock value. Our valuation model uses many indicators to compare PaxMedica, Common value to that of its competitors to determine the firm's financial worth.
PaxMedica, Common Stock is rated below average in total debt category among its peers. It is regarded fifth in debt to equity category among its peers . The ratio of Total Debt to Debt To Equity for PaxMedica, Common Stock is about  2,669,892 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PaxMedica, Common's earnings, one of the primary drivers of an investment's value.

PaxMedica, Total Debt vs. Competition

PaxMedica, Common Stock is rated below average in total debt category among its peers. Total debt of Health Care industry is at this time estimated at about 24.3 Million. PaxMedica, Common maintains roughly 173,543 in total debt contributing less than 1% to equities under Health Care industry.
Total debt  Workforce  Valuation  Capitalization  Revenue

PaxMedica, Debt To Equity vs. Total Debt

Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

PaxMedica, Common

Total Debt

 = 

Bonds

+

Notes

 = 
173.54 K
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

PaxMedica, Common

D/E

 = 

Total Debt

Total Equity

 = 
0.07 %
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.

PaxMedica, Debt To Equity Comparison

PaxMedica, Common is currently under evaluation in debt to equity category among its peers.

PaxMedica, Common Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in PaxMedica, Common, profitability is also one of the essential criteria for including it into their portfolios because, without profit, PaxMedica, Common will eventually generate negative long term returns. The profitability progress is the general direction of PaxMedica, Common's change in net profit over the period of time. It can combine multiple indicators of PaxMedica, Common, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies for the treatment of disorders with intractable neurologic symptoms. PaxMedica, Inc. operates as a subsidiary of Tardimed Sciences LLC. Paxmedica operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 2 people.

PaxMedica, Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on PaxMedica, Common. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of PaxMedica, Common position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the PaxMedica, Common's important profitability drivers and their relationship over time.

Use PaxMedica, Common in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PaxMedica, Common position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PaxMedica, Common will appreciate offsetting losses from the drop in the long position's value.

PaxMedica, Common Pair Trading

PaxMedica, Common Stock Pair Trading Analysis

The ability to find closely correlated positions to PaxMedica, Common could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PaxMedica, Common when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PaxMedica, Common - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PaxMedica, Common Stock to buy it.
The correlation of PaxMedica, Common is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PaxMedica, Common moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PaxMedica, Common Stock moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PaxMedica, Common can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your PaxMedica, Common position

In addition to having PaxMedica, Common in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Retail Thematic Idea Now

Retail
Retail Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Retail theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Retail Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Other Consideration for investing in PaxMedica, Pink Sheet

If you are still planning to invest in PaxMedica, Common Stock check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PaxMedica, Common's history and understand the potential risks before investing.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Volatility Analysis
Get historical volatility and risk analysis based on latest market data